These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 33991474)

  • 41. Letter to the Editor: Breastfeeding and COVID-19 Vaccine: Yes We Can.
    Mayo S; Monfort S
    J Hum Lact; 2021 May; 37(2):275-276. PubMed ID: 33724882
    [No Abstract]   [Full Text] [Related]  

  • 42. SARS-CoV-2: vaccines in the pandemic era.
    Li DD; Li QH
    Mil Med Res; 2021 Jan; 8(1):1. PubMed ID: 33402220
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COVID-19 vaccines: call for global push to maintain efficacy.
    Stöhr K; Cox N
    Nature; 2021 Feb; 590(7844):36. PubMed ID: 33531701
    [No Abstract]   [Full Text] [Related]  

  • 44. Barriers to hospital electronic public health reporting and implications for the COVID-19 pandemic: the authors' reply.
    Holmgren AJ; Apathy NC; Adler-Milstein J
    J Am Med Inform Assoc; 2020 Nov; 27(11):1823-1824. PubMed ID: 33001154
    [No Abstract]   [Full Text] [Related]  

  • 45. Using EM data to understand COVID-19 pathophysiology - Authors' reply.
    Dittmayer C; Meinhardt J; Radbruch H; Radke J; Heppner BI; Heppner FL; Stenzel W; Holland G; Laue M
    Lancet; 2021 Jan; 397(10270):197-198. PubMed ID: 33453781
    [No Abstract]   [Full Text] [Related]  

  • 46. The COVID-19 mRNA Vaccines and the Pandemic: Do They Represent the Beginning of the End or the End of the Beginning?
    Jhaveri R
    Clin Ther; 2021 Mar; 43(3):549-556. PubMed ID: 33579547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The ability of the neonatal immune response to handle SARS-CoV-2 infection - Authors' reply.
    Gale C; Quigley MA; Placzek A; Knight M; Ladhani S; Draper ES; Sharkey D; Doherty C; Mactier H; Kurinczuk JJ
    Lancet Child Adolesc Health; 2021 Mar; 5(3):e8. PubMed ID: 33484657
    [No Abstract]   [Full Text] [Related]  

  • 48. Choices in a Crisis - Individual Preferences among SARS-CoV-2 Vaccines.
    Kramer DB; Opel DJ; Parasidis E; Mello MM
    N Engl J Med; 2021 Apr; 384(17):e62. PubMed ID: 33657289
    [No Abstract]   [Full Text] [Related]  

  • 49. Commentary: SARS-CoV-2 vaccines and cancer patients.
    Corti C; Curigliano G
    Ann Oncol; 2021 Apr; 32(4):569-571. PubMed ID: 33450404
    [No Abstract]   [Full Text] [Related]  

  • 50. Highlight of severe acute respiratory syndrome coronavirus-2 vaccine development against COVID-19 pandemic.
    Liu CH; Huang HY; Tu YF; Lai WY; Wang CL; Sun JR; Chien Y; Lin TW; Lin YY; Chien CS; Huang CH; Chen YM; Huang PI; Wang FD; Yang YP
    J Chin Med Assoc; 2021 Jan; 84(1):9-13. PubMed ID: 33186212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Special issue on COVID-19 data integration opportunities and vaccine development strategies.
    Allmer J
    J Integr Bioinform; 2021 Mar; 18(1):1-2. PubMed ID: 33743557
    [No Abstract]   [Full Text] [Related]  

  • 52. Partial immunity and SARS-CoV-2 mutations.
    Hanage WP; Russell CA
    Science; 2021 Apr; 372(6540):354. PubMed ID: 33888632
    [No Abstract]   [Full Text] [Related]  

  • 53. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial.
    Xia S; Zhang Y; Wang Y; Wang H; Yang Y; Gao GF; Tan W; Wu G; Xu M; Lou Z; Huang W; Xu W; Huang B; Wang H; Wang W; Zhang W; Li N; Xie Z; Ding L; You W; Zhao Y; Yang X; Liu Y; Wang Q; Huang L; Yang Y; Xu G; Luo B; Wang W; Liu P; Guo W; Yang X
    Lancet Infect Dis; 2021 Jan; 21(1):39-51. PubMed ID: 33069281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytokines as predictors of COVID-19 severity: evidence from a meta-analysis. Authors' reply.
    Kosmaczewska A; Frydecka I
    Pol Arch Intern Med; 2021 Jan; 131(1):99-100. PubMed ID: 33522219
    [No Abstract]   [Full Text] [Related]  

  • 55. Cytokines as predictors of COVID-19 severity: evidence from a meta-analysis. Authors' reply.
    Marcinkiewicz J; Majka G
    Pol Arch Intern Med; 2021 Jan; 131(1):100. PubMed ID: 33522220
    [No Abstract]   [Full Text] [Related]  

  • 56. Coagulation Abnormalities Due to COVID-19 in a Child with Thalassemia: Authors' Reply.
    Marhaeni W; Wijaya AB
    Indian J Pediatr; 2021 Jul; 88(7):737. PubMed ID: 34097233
    [No Abstract]   [Full Text] [Related]  

  • 57. Parliamentary committee report on covid-19 response: the difference between an apology and repentance.
    Caan W
    BMJ; 2021 Nov; 375():n2813. PubMed ID: 34794960
    [No Abstract]   [Full Text] [Related]  

  • 58. Science and beyond science in the reporting of quality of facility-based maternal and newborn care during the COVID-19 pandemic-Authors' reply.
    Lazzerini M; Costa R; Mariani I; Vik ES; Elden H; Linden K; Zaigham M; Liepinaitienė A; Arendt M; Drglin Z; Sacks E; Lincetto O; Valente EP;
    Lancet Reg Health Eur; 2022 Sep; 20():100488. PubMed ID: 35996590
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical trial reporting - Authors' reply.
    DeVito NJ; Goldacre B
    Lancet; 2020 Nov; 396(10261):1489-1490. PubMed ID: 33160569
    [No Abstract]   [Full Text] [Related]  

  • 60. Covid-19: Sputnik vaccine rockets, thanks to Lancet boost.
    van Tulleken C
    BMJ; 2021 May; 373():n1108. PubMed ID: 33958384
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.